Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

TNF inhibitors and cardiovascular risk: Friend or foe?

Journal of the European Academy of Dermatology and Venereology(2024)10.1111/jdv.20017Source: DataRank Database

TNF inhibitors and cardiovascular risk: Friend or foe? is a research paper published in Journal of the European Academy of Dermatology and Venereology (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.64)OA: bronzeTopics (30)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Michael Garshick ORCID,Joel M. Gelfand ORCID

Live enrichment

PubMed:38794923 PMC:PMC11141718 OpenAlex:https://openalex.org/W4399007600

NIH/NIAMS

Grant: 5P30AR069589 (JMG)

NIAMS NIH HHS

Grant: P30 AR069589

FWCI

0.64

Citation Percentile

0.6%

Citation Trend

2025

2026

bronzeLicense: http://onlinelibrary.wiley.com/termsAndConditions#vor

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jdv.20017

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jdv.20017

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.20017

journalhttps://doi.org/10.1111/jdv.20017

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38794923

Fields of Study

Psoriasis: Treatment and PathogenesisRheumatoid Arthritis Research and TherapiesInflammasome and immune disordersHumansCardiovascular DiseasesTumor Necrosis Factor-alphaHeart Disease Risk FactorsRisk FactorsPsoriasis

MeSH Terms

Heart Disease Risk FactorsCardiovascular DiseasesHumansPsoriasisRisk FactorsTumor Necrosis Factor-alpha

Keywords

MedicineMaceCanakinumabInternal medicinePlaceboRheumatoid arthritisAdalimumabPsoriatic arthritisImmunologyOncologyDiseaseMyocardial infarctionAnakinraPathologyPercutaneous coronary intervention

Sustainable Development Goals

SDG 0: Zero hunger